butaclamol has been researched along with n-(4-azido-3-iodophenethyl)spiperone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetto, P; Feigenblum, D; Filer, D; Goldstein, M; Lew, JY; Tang, D; Zawadzka, H | 1 |
| Amlaiky, N; Caron, MG | 1 |
2 other study(ies) available for butaclamol and n-(4-azido-3-iodophenethyl)spiperone
| Article | Year |
|---|---|
Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Topics: Animals; Azides; Blotting, Northern; Butaclamol; Corpus Striatum; Female; Haloperidol; In Vitro Techniques; Kinetics; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred BUF; Receptors, Dopamine; RNA, Messenger; Spiperone | 1990 |
Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
Topics: Affinity Labels; Animals; Azides; Butaclamol; Butyrophenones; Cell Membrane; Corpus Striatum; Dopamine Antagonists; Female; Iodine Radioisotopes; Molecular Weight; Photochemistry; Protease Inhibitors; Rats; Receptors, Dopamine; Spiperone | 1985 |